Nicotinic-serotonergic drug interactions and attentional performance in rats

Psychopharmacology

Volumn 179, Issue 3, 2005, Pages 521-528

  Rezvani, Amir H ^a   Caldwell, D Patrick ^a   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Attention; Cognition; Ketanserin; Nicotine; Serotonin; Serotonin antagonists; Signal detection task

Indexed keywords

KETANSERIN; KETANSERIN TARTRATE; NICOTINE; NICOTINE TARTRATE; NICOTINIC AGENT; SEROTONIN 2A ANTAGONIST;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; ATTENTION; COGNITION; CONTROLLED STUDY; FEMALE; INSTRUMENTAL CONDITIONING; NONHUMAN; OSMOTIC PUMP; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

ANIMALS; ATTENTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; KETANSERIN; NICOTINE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN ANTAGONISTS;

EID: 18744376606     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2060-y     Document Type: Article

References (49)

1. Antoniou K, Berkis S, Saranti M, Stathis P, Rimikis M, Papadopoulou-Daifoti Z (2000) The effects of antipsychotic drugs on serotonergic activity in the rat hippocampus. Eur Neuropharmacol 10:315-324
2. Buhot MC (1997) Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 7:243-254
3. Bushnell P (1998) Behavioral approaches to the assessment of attention in animals. Psychopharmacology 138:231-259
4. Bushnell PJ, Oshiro WM, Padnos BK (1997) Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention. Psychopharmacology 134:230-241
5. Damaj MI, Glennon RA, Martin BR (1994) Involvement of the serotonergic system in the hypoactive and antinociceptive effects of nicotine in mice. Brain Res Bull 33:199-203
6. Engberg G, Hajos M (1994) Nicotine-Induced activation of locus coeraleus neurons an analysis of peripheral versus central induction. Naunyn Schmiedeberg's Arch Pharmacol 349:443-446
7. Friedman JI, Adler DN, Howanitz E, Harvey PD, Brenner G, Temporini H, White L, Parrella M, Davis KL (2003) A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biol Psychiatry 51:349-357
8. Grilly DM, Simon BB, Levin ED (2000) Nicotine enhances stimulus detection performance of middle- and old-aged rats: a longitudinal study. Pharmacol Biochem Behav 65:665-670
9. Jäkälä P, Sirvio J, Jolkkonen J, Riekkinen P Jr, Acsady L, Riekkinen P (1992) The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. Behav Brain Res 51:29-40
10. Lawrence AD, Sahakian BJ (1995) Alzheimer's disease, attention, and the cholinergic system. Alzheimer Dis Assoc Disord 9:43-49
11. Levin E, Wilson W, Rose J, McEvoy J (1996a) Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436
12. Levin ED, Conners CK, Sparrow E, Hinton S, Meck W, Rose JE, Ernhardt D, March J (1996b) Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 123:55-63
13. Levin ED, Conners CK, Silva D, Hinton SC, Meck W, March J, Rose JE (1998) Transdermal nicotine effects on attention. Psychopharmacology 140:135-141
14. Levin ED, Conners CK, Silva D, Canu W, March J (2001) Effects of chronic nicotine and methylphenidate in adults with ADHD. Exp Clin Psychopharmacol 9:83-90
15. Lichtensteiger W, Ribary U, Schlumpf M, Odermatt B, Widmer R (1988) Prenatal adverse effects of nicotine on the developing brain. Prog Brain Res 73:137-157
16. Lubow R (1997) Latent inhibition as a measure of learned intention: some problems and solutions. Behav Brain Res 88:75-83
17. Mar C, Smith DA, Sarter M (1996) Behavioral vigilance in schizophrenia: evidence for hyperattentional processing. Br J Psychiatry 169:781-789
18. McGaughy J, Decker MW, Sarter M (1999) Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats. Psychopharmacology 144:175-182
19. Meltzer H (1995) Atypical antipsychotic drugs. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 1277-1286
20. Mirza NR, Bright JL (2001) Nicotine-induced enhancements in the five-choice serial reaction time task in rats are strain-dependent. Psychopharmacology 154:8-12
21. Mirza NR, Stolerman IP (1998) Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology 138:266-274
22. Mirza NR, Pei Q, Stolerman IP, Zetterstrom TSC (1996) The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens. Eur J Pharmacol 295:207-210
23. 3 receptor antagonist, ondansetron. Psychopharmacology 118:82-92
24. Murrin LC, Ferrer JR, Wanyun Z, Haley NJ (1987) Nicotine administration to rats: methodological considerations. Life Sci 40:1699-1708
25. Peeke SC, Peeke HVS (1984) Attention, memory, and cigarette smoking. Psychopharmacology 84:205-216
26. 2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study. Eur Neuropsychopharmacol 13:123-128
27. Rezvani AH, Levin ED (2003a) Nicotine interactions with the NMDA glutaminergic antagonist dizocilpine and attentional function. Eur J Pharmacol 465:83-90
28. Rezvani AH, Levin ED (2003b) Nicotine-alcohol interactions and attentional performance on an operant visual signal detection task in female rats. Pharmacol Biochem Behav 76:75-83
29. Rezvani AH, Levin ED (2004) Nicotine-antipsychotic drug interactions and attentional performance in female rats. Eur J Pharmacol 486:175-182
30. Rezvani AH, Bushnell PJ, Burkholder JM, Glasgow HB, Levin ED (2001) Specificity of cognitive impairment from Pfiesteria piscicida exposure in rats: attention and visual function vs behavioral plasticity. Neurotoxicol Teratol 23:609-616
31. Rezvani AH, Bushnell P, Levin ED (2002) Nicotine and mecamylamine effects on choice accuracy in an operant signal detection task. Psychopharmacology 164:369-375
32. 2 antagonist ritanserin blocks dopamine reuptake in the rat frontal cortex. Mol Psychiatry 5:673-677
33. Ruotsalainen S, Sirvio J, Jäkälä P, Puumala T, MacDonald E, Riekkinen P Sr (1997) Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks. Eur Neuropsychopharmacol 7:99-108
34. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type. Br J Psychiatry 154:797-800
35. Sanders-Bush E, Mayer SE (2001) 5-Hydroxytryptamine (serotonin): receptor agonists and antagonists. In: Hardman JG, Limbird L, Goodman Gilman AG (eds) The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, pp 269-290
36. Sarter M, Givens B, Bruno JP (2001) The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Res Rev 35:146-160
37. Seth P, Cheeta S, Tucci S, File SE (2002) Nicotine-serotonergic interactions in brain and behavior. Pharmacol Biochem Behav 71:795-805
38. Slotkin TA (1992) Prenatal exposure to nicotine: what can we learn from animal models? In: Zagon IS, Slotkin TA (eds) Maternal substance abuse and the developing nervous system. Academic, New York, pp 97-124
39. Solomon P, Kiney C, Scott D (1978) Disruption of latent inhibition following systemic administration of parachlorophenylalanine (PCPA). Physiol Behav 20:265-271
40. Solomon P, Nichols G, Kiernan J, Kamor R, Kaplan L (1980) Differential effects of lesions in medial and dorsal raphe of the rat: latent inhibition and septohippocampal serotonin levels. J Comp Physiol Psychol 94:145-154
41. Stolerman IP, Mirza NR, Hahn B, Shoaib M (2000) Nicotine in an animal model of attention. Eur J Pharmacol 393:147-154
42. Summers KL, Giacobini E (1995) Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem Res 20:753-759
43. Trauth JA, Seidler FJ, McCook EC, Slotkin TA (1999) Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res 851:9-19
44. Turchi J, Holley LA, Sarter M (1995) Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats. Psychopharmacology 118:195-205
45. 2 receptor blocking agent, ritanserin, in the rat. Eur Neuropsychopharmacol 6:305-310
46. Warburton DM, Rusted JM, Fowler J (1992) A comparison of the attentional and consolidation hypotheses for the facilitation of memory by nicotine. Psychopharmacology 108:443-447
47. White HK, Levin ED (1999) Chronic four week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology 143:158-165
48. 2A receptors in working memory. J Neurosci 22:2843-2854
49. Wonnacott S (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci 20:92-98